Dovitinib
Catalog No: 122943
CAS Number: 1447274-99-8
Purity: 98%
Dovitinib is a benzimidazole-quinolinone compound and receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.
For research use only. We do not sell to patients.
Chemical Information
| Name | Dovitinib |
|---|---|
| Iupac Chemical Name | (3E)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one |
| Synonyms | CHIR-258; TKI258; TKI-258; TKI 258; CHIR258; CHIR 258 |
| Molecular Formula | C21H21FN6O |
| Molecular Weight | 392.4290 |
| Smile | CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3 |
| InChiKey | KCOYQXZDFIIGCY-UHFFFAOYSA-N |
| InChi | InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11,24-25H,7-10,23H2,1H3 |
| CAS Number | 1447274-99-8 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
